Navigation Links
Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
Date:3/13/2008

results it expects, and such other risks as identified in the company's quarterly report on Form 10-K for the period ended December 31, 2007, and from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com. Trubion undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

TRBN-G

For more information, contact:

Trubion Pharmaceuticals Inc.

Jim DeNike

Senior Director, Corporate Communication

(206) 838-0500

jdenike@trubion.com

Waggener Edstrom Healthcare

Jenny Moede

Senior Vice President

(503) 443-7000

jmoede@wagged.com

(Tables Follow)

TRUBION PHARMACEUTICALS. INC.

STATEMENTS OF OPERATIONS

(In thousands, except per share data)

Three months Twelve months

ended ended

December 31, December 31,

2007 2006 2007 2006

Revenue $5,698 $6,355 $20,148 $36,530

Operating expenses:

Research and development 8,265 9,858 36,466 33,309

General and administrative 3,181 2,372 10,833 9,473

Total operating expenses 11,446 12,230 47,299 42,782

Loss from operations (5,748) (5,875) (27,151) (6,252)

Interest income
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Trubion Pharmaceuticals to Present at the Lazard Capital Markets Healthcare Investor Conference
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results
3. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
4. Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
5. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
6. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
7. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
8. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
9. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Research ... "Global Genomics and Proteomics Analytical Instruments Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Genomics is the study ... the study of the structure and functions of proteomes ... bioinformatics tools and technology. Genomics involves the mapping of ...
(Date:7/24/2014)... , July 24, 2014 SRI International ... with the National Institute of Allergy and Infectious Diseases ... conduct preclinical development of potential therapies for HIV infection ... to treat HIV and AIDS and the complications and ... microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 Three ... be semi-finalists in Livestrong’s Big C Competition. Out of ... are each headed to the semi-final round. In this ... exclusive three-month accelerator program, complete with mentoring from thought-leaders ... , As part of the angelMD commitment to the ...
(Date:7/24/2014)... , July 24, 2014  Neogen Corporation (Nasdaq: ... forecasts of its potential revenue from new rodenticide research ... investors and analysts on July 22, 2014, Neogen,s CEO ... regarding this research. "It was my intent ... the potential of a new type of rodenticide, but ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 33 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2
... the country's largest HMO announced it would discontinue a ... medical record system -- called the Clinical Information System ... Epic Systems , a relatively small private software developer ... ,So far, at least, Epic's been up to the ...
... it has also gotten on board with the real-time ... example of real-time technology. WisconsinGuide.com is helping to bring ... industry by allowing business owners the ability to quickly, ... , ,WisconsinGuide.com was featured on the WMTV NBC ...
... complaints of poor service from Wisconsin customers two years ago ... ,Paul La Schiazza, president of SBC's Wisconsin division said that ... was not a small local company, but a large corporation ... SBC Communications Inc. announced that SBC Ameritech of Wisconsin would ...
Cached Biology Technology:Kaiser On Schedule With Epic's Epic Project 2Kaiser On Schedule With Epic's Epic Project 3Wisconsin Tourism Aided by Internet Technology 2Wisconsin Tourism Aided by Internet Technology 3SBC is Here to Stay 2
(Date:7/25/2014)... use of a molecular testing panel developed at ... correct initial surgery for patients with thyroid nodules ... Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter., ... Center and other diagnostic testing agencies, improved the ... by 30 percent, according to the study published ...
(Date:7/24/2014)... (July 24, 2014) Scientists at The New ... one step closer to creating a viable cell ... own cells. , For the first time, ... lines from skin samples of patients with primary ... accelerated protocol to induce these stem cells into ...
(Date:7/24/2014)... DIEGO , July 24, 2014 /PRNewswire-iReach/ -- The ... data from cardiac devices, has cut emergency room wait ... UC San Diego (UCSD) Medical Center, according to a ... The UCSD Emergency Departments are using the suite to ... as pacemakers or defibrillators. "Using Geneva,s technology ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
... CHAMPAIGN, Ill. We all know one, or think we ... his or her actual merits. Popular culture labels these folks ... suggests that some forms of narcissism are at least ... difficult transition to adulthood. The study appears ...
... relatively simple combination of naturally occurring sugars and amino acids ... according to a paper published in Nature Chemistry ... The study, " A Route to Enantiopure RNA Precursors ... to RNA could have formed on Earth before any life ...
... --- Farmers and policymakers should wait before converting Conservation Reserve ... Michigan State University study. The study, which appears ... National Academy of Sciences , focuses on CRP land, a ... than crops, and its role in the production of biofuels. ...
Cached Biology News:Narcissism may benefit the young, researchers report; but older adults? Not so much 2To avoid carbon debt, CRP beats fields of corn, soybeans 2